Drep.Afrique aims to act against sickle cell disease and help raise public awareness on the scourge that is the most common genetic disease in the world, which is too often ignored. Its aim is to initiate actions and concrete projects to prevent, detect, treat and increase the life expectancy of people affected by sickle cell disease, where this disease hits hardest, mainly on the African continent.
A Universal Challenge
The fight against sickle cell disease has been one of the WHO’s priorities for Africa since 2009 and ranks fourth in global public health after cancer, HIV and malaria. It is the most common genetic disease in the world.
Every minute in Africa, a child is born with sickle cell disease. Unfortunately, one person dies every 2 minutes.
A few words from our President
“Together, let's make the gesture, the action, a donation to save the lives of millions of sickle-cell children”
Robert HUE, Founding President of Drep.Afrique, former Senator.
Professor Jean-Benoît ARLET, Doctor, Researcher, Coordinator of the scientific council of Drep.Afrique.
"Thanks to your generosity, Drep.Afrique launched its inter-university degree on sickle cell disease in African countries in 2021. We are calling on as many people as possible to enable us to train the maximum number of doctors and effectively combat this global health scourge.”
Active financial partners
'Inidex GRex Université de Paris Cité (research grant)'
And to all the anonymous contributors that support us
Thanks to you, in 4 years, Drep.Afrique is :
-
2,500 African caregivers trained in sickle cell disease from 17 countries of French-speaking Africa, including 260 with a diploma expert training (DIU Drep.Afrique-Paris-Cité-Universités Africaines)
-
60 teachers, medical professors or not, mobilized from France, Belgium and 10 French-speaking African countries.
-
The publication in a scientific journal of recommendations adapted to the African field to better treat patients
-
A brand of medicine and a unique model of partnership to produce and distribute the essential medicine for this disease in Africa, to as many people as possible and at the lowest cost
News from Drep.Afrique
As part of our commitment to raising awareness about sickle cell disease, we are pleased to partner with the "1 MONTH, 1 CAUSE" initiative led by the CANAL+ Group. Through this program, the group highlights a major cause each month on its channels in Africa, in the fields of health, social issues, and humanitarian action.
From January 19 to February 18, 2026, the fight against sickle cell disease will be highlighted through the broadcast of our commercial, accompanying the launch of DREPAF in Senegal. This treatment, locally manufactured and sold at cost price thanks to a humanitarian partnership between our NGO and Teranga Pharma, helps reduce painful crises, hospitalizations, and mortality among patients with sickle cell disease living in Africa by threefold.
The free broadcast of our commercial, made possible by the shared commitment of CANAL+ and DREP AFRIQUE, aims to increase the visibility of sickle cell disease.
FIFDA 2025
27 of may 2025
💥Free registration
We are waiting for you!!
inscription via email : diudrepafrique2@gmail.com
FIFDA 2025
FIFDA 2025
💥Free registration
We are waiting for you!!
(Program available soon)
.png)
FIFDA 2025
FIFDA 2025
27 of may 2025
💥Free registration
We are waiting for you!!
inscription via email : diudrepafrique2@gmail.com
Meeting
Meeting between the Minister of Health and Social Action of Senegal, Dr Ibrahima SY and Robert HUE, President of the NGO Drep.Afrique for the fight against sickle cell disease. Recalling the major scourge of sickle cell disease on the African continent, the most common genetic disease in the world, Mr HUE spoke about the actions undertaken by Drep.Afrique in Senegal, including the three-year training of nearly 200 African caregivers to manage sickle cell disease.
Contact
Address
193 avenue du Maine, 75014 Paris
Phone
+33 9 61 56 92 41
Social media
